Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 636 participants.

Also called NCT07687186

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 636 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07687186
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07687186. Randomized; quadruple masking; primary purpose treatment. Start 2026-08-21 (actual); primary completion 2028-06-22 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Condition
Heart Failure
Intervention (Drug)
Qishen Yiqi Dripping Pills 2 bags
Intervention (Drug)
Qishen Yiqi Dripping Pills placebo 2 bags
Lead sponsor
Tasly Pharmaceutical Group Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct07687186
Content hash
f33ae3d7680ae34ae94e0caab7bf5e6099e86f0f685e1cf575127e170a9b8b14